Therapy Areas: Respiratory
Biodesix to Participate at Cowen's 43rd Annual Healthcare Conference
2 March 2023 - - Scott Hutton, chief executive officer of US-based diagnostic solutions company Biodesix, Inc. (NASDAQ: BDSX), will participate in a fireside chat and host in-person 1x1 investor meetings at Cowen's 43rd Annual Healthcare Conference being held from March 6-8, 2023, the company said.

Cowen's 43rd Annual Healthcare Conference

Fireside Chat Date: Tuesday, March 7, 2023
Fireside Chat Time: 1:30 PM ET
Location: Boston Marriott Copley Place

The fireside chat will be webcast live and available for replay under "News & Events" in the Investors section of the company's website at www.biodesix.com.

Biodesix is a data-driven diagnostic solutions company with a focus in lung disease. The company develops diagnostic tests addressing important clinical questions by combining multi-omics through the power of artificial intelligence.
Login
Username:

Password: